Skip to main content

Table 1 Clinical characteristics of patients

From: Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans

CHS Age (YEARS) M/F CS (%) TC TG HDL LDL SBP DBP DM HT (%) HL (%) P
Stroke (24 h)              
LA (n = 10) 62 ± 7 5/5 2 (20%) 4.48 ± 0.71 1.53 ± 0.43 1.13 ± 0.18 2.53 ± 0.58 132 ± 12 84 ± 13 1 (10%) 2 (20%) 2 (20%) 0.12
SA (n = 9) 63 ± 6 4/5 2 (22%) 4.32 ± 0.63 1.43 ± 0.23 1.24 ± 0.16 2.42 ± 0.61 125 ± 10 82 ± 14 2 (22%) 2 (22%) 1 (11%) 0.32
CEmb (n = 9) 64 ± 5 5/4 1 (11%) 4.18 ± 0.52 1.23 ± 0.18 1.02 ± 0.12 2.43 ± 0.47 130 ± 12 85 ± 11 1 (11%) 1 (11%) 1 (11%) 0.46
UDN (n = 10) 61 ± 6 5/5 2 (20%) 4.23 ± 0.34 1.36 ± 0.33 1.25 ± 0.27 2.45 ± 0.45 135 ± 13 80 ± 13 1 (10%) 2 (20%) 2 (20%) 0.78
Stroke (1 W)              
LA (n = 11) 65 ± 6 5/6 2 (18%) 4.12 ± 0.25 1.54 ± 0.46 1.15 ± 0.12 2.50 ± 0.35 128 ± 14 82 ± 10 1 (9%) 2 (18%) 2 (20%) 0.98
SA (n = 10) 66 ± 4 5/5 2 (20%) 4.16 ± 0.32 1.44 ± 0.35 1.10 ± 0.17 2.43 ± 0.42 138 ± 27 86 ± 14 1 (10%) 2 (20%) 1 (10%) 0.54
CEmb (n = 11) 62 ± 7 6/5 2 (18%) 4.31 ± 0.17 1.32 ± 0.38 1.15 ± 0.14 2.46 ± 0.38 137 ± 10 85 ± 13 1 (9%) 1 (9%) 1 (9%) 0.65
UDN (n = 10) 63 ± 7 4/6 2 (20%) 4.42 ± 0.54 1.42 ± 0.43 1.17 ± 0.12 2.35 ± 0.36 132 ± 15 87 ± 11 1 (10%) 1 (10%) 1 (10%) 0.98
Stroke (4 W)              
LA (n = 10) 65 ± 5 6/4 2 (20%) 4.39 ± 0.47 1.55 ± 0.39 1.18 ± 0.13 2.62 ± 0.56 130 ± 12 88 ± 10 1 (10%) 2 (20%) 2 (20%) 0.82
SA (n = 10) 64 ± 7 4/6 1 (10%) 4.36 ± 0.52 1.36 ± 0.36 1.09 ± 0.13 2.43 ± 0.34 129 ± 16 85 ± 11 2 (20%) 2 (20%) 1 (10%) 0.12
CEmb (n = 10) 63 ± 7 5/5 2 (20%) 4.26 ± 0.17 1.38 ± 0.29 1.12 ± 0.17 2.43 ± 0.33 130 ± 12 86 ± 10 1 (10%) 1 (10%) 1 (10%) 0.12
UDN (n = 10) 64 ± 6 6/4 2 (20%) 4.24 ± 0.43 1.42 ± 0.35 1.19 ± 0.16 2.44 ± 0.44 127 ± 13 82 ± 12 1 (10%) 2 (20%) 1 (10%) 0.34
Stroke (24 W)              
LA (n = 10) 65 ± 7 6/4 1 (10%) 4.36 ± 0.27 1.56 ± 0.42 1.14 ± 0.15 2.43 ± 0.56 126 ± 15 88 ± 12 1 (10%) 2 (20%) 2 (20%) 0.87
SA (n = 9) 66 ± 6 4/5 1 (11%) 4.39 ± 0.59 1.44 ± 0.32 1.17 ± 0.12 2.39 ± 0.45 124 ± 13 83 ± 11 2 (22%) 2 (22%) 1 (11%) 0.23
CEmb (n = 10) 64 ± 5 5/5 1 (10%) 4.35 ± 0.49 1.37 ± 0.41 1.15 ± 0.16 2.50 ± 0.43 126 ± 15 85 ± 12 1 (10%) 1 (10%) 1 (10%) 0.13
UDN (n = 9) 65 ± 6 5/4 1 (11%) 429 ± 0.39 1.49 ± 0.29 1.19 ± 0.18 2.45 ± 0.45 125 ± 13 86 ± 11 1 (11%) 1 (11%) 1 (11%) 0.56
Stroke (48 W)              
LA (n = 10) 64 ± 7 6/4 2 (20%) 4.46 ± 0.28 1.57 ± 0.42 1.15 ± 0.13 2.55 ± 0.43 127 ± 12 84 ± 12 1 (10%) 2 (20%) 2 (20%) 0.11
SA (n = 10) 66 ± 5 5/5 2 (20%) 4.35 ± 0.42 1.43 ± 0.32 1.17 ± 0.20 2.46 ± 0.53 123 ± 11 83 ± 10 2 (20%) 1 (10%) 1 (10%) 0.45
CEmb (n = 10) 65 ± 7 4/6 1 (10%) 4.37 ± 0.42 1.38 ± 0.41 1.23 ± 0.15 2.61 ± 0.53 125 ± 10 87 ± 14 1 (10%) 1 (10%) 1 (10%) 0.55
UDN (n = 9) 64 ± 8 5/4 1 (11%) 4.44 ± 0.32 1.42 ± 0.33 1.17 ± 0.18 2.65 ± 0.62 129 ± 13 87 ± 13 1 (11%) 1 (10%) 1 (10%) 0.87
Healthy outpatient (n = 50) 64 ± 6 24/26 10 (20%) 4.52 ± 0.48 1.39 ± 0.40 1.15 ± 0.14 2.50 ± 0.62 125 ± 11 82 ± 11 5 (10%) 5 (10%) 6 (12%)  
  1. CHS, Characteristics; M/F, Male/female; CS, Current smoking; TC, total cholesterol (mmol/L); TG, total glyceride (mmol/L); HDL, high-density lipoprotein (mmol/L); LDL, low-densitlipoprotein (mmol/L); SBP, systolic blood pressure (mmHg); DBP, diastolic blood pressure (mmHg); DM, diabetes mellitus; HT, Hypertension; HL, Hyperlipidaemia; LA, Large artery stroke; SA, Small artery stroke; CEmb, Cardioembolic stroke; UDN, stroke due to undetermined cause; P, comparison between patients with healthy adult.